Clackamas Health Centers (CHC), a public sector Federally Qualified Health Center in Oregon, provides medication for opioid use disorder (MOUD) in a low-barrier model, featuring a unique pathway for criminal justice-involved patients. CHC's primary care-based treatment program has seen substantial growth since it began. These data can help demonstrate the effectiveness of fully-integrated MOUD programs in primary care, as well as establishing a baseline for treatment outcomes and future program evaluation.

PRA’s Toolkit for Writing an RFP to Contract for Healthcare Services in a Correctional or Detention Institution (Correctional Healthcare RFP Toolkit) is designed to help correctional and detention facilities—along with local governments—create effective, outcome-focused requests for proposals (RFPs) for healthcare services.

NCCHC’s Jail Guidelines for the Medical Treatment of Substance Use Disorders, 2025, provides the latest research and best practices for addressing the opioid crisis and ensuring that incarcerated individuals receive effective treatment.

Qualitative study of staff in rural Colorado jails identifies facilitators and barriers to MOUD adoption and expansion, including resource constraints and attitudes.

This graphic provides recommended protocols throughout the entire cycle of medication for opioid use disorder (MOUD) treatment in jails to prevent diversion, as outlined in a 2023 study by Justice Community Overdose Innovation Network (JCOIN) researchers.

This report covers how local jails screen for and treat opioid use disorder, highlighting the frequency of screenings during admission, the rate of positive results, and how many inmates receive medication for withdrawal and treatment.

This toolkit offers correctional administrators and health care providers essential information for planning and implementing MAT programs in jails and prisons. It includes actionable steps, implementation questions, case examples, checklists, and resources from recent research and expert experiences across the U.S.

This document provides jail and prison administrators, program managers, medical staff in correctional settings, and reentry staff with a performance management framework to monitor medication-assisted treatment (MAT) in correctional settings.

Highlights the important evidence-based practices recommended in the Substance Abuse and Mental Health Services Administration’s (SAMHSA) latest and most comprehensive guidance regarding pregnant women with opioid use disorders.

Key issues surrounding medication assisted treatment (MAT), the evidence that underlies treatment types for opioid use disorder, best practices, and legal implications.